Jianguo Liu, M.D., Ph.D.
Dr. Liu obtained his medical degree and was trained in internal medicine at Hebei Medical University. He received his Ph.D. in Immunology at Peking University Health Science Center. He completed his postdoctoral training in the Department of Microbiology and Immunology at Weill Medical College of Cornell University and won several awards from AAI and ISICR. He came to Saint Louis University in 2008 as an independent investigator to study the roles of cytokines and chemokines in the pathogenesis of human diseases, with particular interest in Mycobacterial tuberculosis, breast cancer and autoimmune diseases. The goals of Dr. Liu's research are to develop novel therapeutic approaches to treat these diseases by targeting inflammatory cytokines.
Dr. Liu's work has being funded by the NIH and by internal grants. Ongoing projects in Dr. Liu's lab include focus on investigation of (1) the role of RNA-binding proteins in control of breast cancer growth and metastasis, (2) the role of the IL-12 cytokine family in protective immunity directed against Mycobacterial tuberculosis, and (3) the role of inflammatory cytokines in the pathogenesis of SLE and Juvenile Idiopathic Arthritis.